Romania Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International
March 20, 2012
100 Pages - SKU: BMI3816816
Big Data and Healthcare
8/26/2014 | published by: Kalorama Information
Big Data and Healthcare Big data consists of the enormous datasets that flow daily from manufacturers, healthcare providers, regulatory bodies, scientists and others. Those working with big data are seeking insights  |  read more...
USD 750
Advanced Remote Patient Monitoring Systems, 7th Edition
9/9/2014 | published by: Kalorama Information
Advanced Remote Patient Monitoring Systems, 7th Edition For their potential to reduce healthcare costs and improve patient outcomes, patient monitoring systems with advanced capabilities are among the fastest-growing devices in  |  read more...
USD 4,200
Biopharmaceutical and Vaccine Production Markets
8/29/2014 | published by: Kalorama Information
Biopharmaceutical and Vaccine Production Markets   Though biotechnology has created many new therapies and vaccines – including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders – there are still huge  |  read more...
USD 3,995
Consumer Health - Italy
9/17/2014 | published by: Euromonitor International
Consumer Health in Italy 2013 was a difficult year for Italy, which continued to face significant economic and political uncertainty. Italian consumers tended to avoid purchases of unnecessary items and tried to optimise their spending in  |  read more...
USD 2,400
Temperature Management Market by Product (Surface & Intravascular Systems- Warming & Cooling), Application (Acute & Perioperative Care, Delivery Suite) & by End User (Surgeon & Anesthesiologist, Nursing & Paramedical Staff) - Global Forecasts & Trends to
9/18/2014 | published by: MarketsandMarkets
Temperature Management Market by Product (Surface & Intravascular Systems- Warming & Cooling), Application (Acute & Perioperative Care, Delivery Suite) & by End User (Surgeon & Anesthesiologist, Nursing & Paramedical Staff) - Global Forecasts & Trends  |  read more...
USD 4,650
Secondary Hyperparathyroidism - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Secondary Hyperparathyroidism - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H2 2014’, provides an overview of the Secondary Hyperparathyroidism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Secondary  |  read more...
USD 2,000
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Cleanroom Technology Market by Equipment (HVAC System, HEPA Filter, Air Shower, Air Diffuser), Consumables (Apparel, Gloves, Wipes, Disinfectants), Construction (Hardwall, Softwall), & by End User (Pharmaceutical, Biotech) – Global Forecast to 2019
9/15/2014 | published by: MarketsandMarkets
Cleanroom Technology Market by Equipment (HVAC System, HEPA Filter, Air Shower, Air Diffuser), Consumables (Apparel, Gloves, Wipes, Disinfectants), Construction (Hardwall, Softwall), & by End User (Pharmaceutical, Biotech) – Global Forecast to 2019 The increasing  |  read more...
USD 4,650
Premature Ejaculation - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Premature Ejaculation - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Premature Ejaculation - Pipeline Review, H2 2014’, provides an overview of the Premature Ejaculation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Premature  |  read more...
USD 2,000
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Recurrent Head  |  read more...
USD 2,000
 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,175  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!